Back to 
BAKER BROS. ADVISORS LP
BAKER BROS. ADVISORS LP
GHDXShowing 0 of 4 quarters
Position history for BAKER BROS. ADVISORS LP's holdings in GENOMIC HEALTH INC
As of its Q3 2019 13F, Baker Bros. Advisors held 9,244,665 shares of GHDX (Genomic Health), worth $627M. Baker Bros. Advisors' 13F filings listed GHDX from Q1 2019 to Q3 2019, 3 quarterly filings. GHDX was 4.3% of Baker Bros. Advisors' reported 13F portfolio.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of GHDX: RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, Invesco Ltd., Man Group plc, DEUTSCHE BANK AG\